Search

Your search keyword '"Monahan, Patrick"' showing total 8 results
Start Over Author "Monahan, Patrick" Journal cancer
8 results on '"Monahan, Patrick"'

2. Randomized clinical trial of therapeutic music video intervention for resilience outcomes in adolescents/young adults undergoing hematopoietic stem cell transplant: A report from the Childrenʼs Oncology Group

Author

Robb, Sheri L., Burns, Debra S., Stegenga, Kristin A., Haut, Paul R., Monahan, Patrick O., Meza, Jane, Stump, Timothy E., Cherven, Brooke O., Docherty, Sharron L., Hendricks-Ferguson, Verna L., Kintner, Eileen K., Haight, Ann E., Wall, Donna A., and Haase, Joan E.

Published
2014
Full Text
View/download PDF

6. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3‐arm pilot randomized controlled trial

Author

Johns, Shelley A., primary, Stutz, Patrick V., additional, Talib, Tasneem L., additional, Cohee, Andrea A., additional, Beck‐Coon, Kathleen A., additional, Brown, Linda F., additional, Wilhelm, Laura R., additional, Monahan, Patrick O., additional, LaPradd, Michelle L., additional, Champion, Victoria L., additional, Miller, Kathy D., additional, and Giesler, R. Brian, additional

Published
2019
Full Text
View/download PDF

7. Improving the quality of life of patients with prostate carcinomaThis research was conducted in affiliation with the Mary Margaret Walther Program for Cancer Care Research and the Behavioral Cooperative Oncology Group.: A randomized trial testing the efficacy of a nurse‐driven intervention

Author

Giesler, R. Brian, Given, Barbara, Given, Charles W., Rawl, Susan, Monahan, Patrick, Burns, Debra, Azzouz, Faouzi, Reuille, Kristina M., Weinrich, Sally, Koch, Michael, and Champion, Victoria

Abstract

Treatments for clinically localized prostate carcinoma are accompanied by sexual, urinary, and bowel dysfunction and other sequelae that can result in significant distress and reduced well being. Methods capable of improving quality of life are needed that can be integrated into clinical practice. To address this need, a nurse‐driven, cancer care intervention was developed and tested.Within 6 weeks after completing treatment, 99 patients, along with their partners, were enrolled into a prospective, controlled trial and were randomized to receive the cancer care intervention or to receive standard care. Participants in the intervention arm met once each month for 6 months with an oncology nurse intervenor, who helped patients identify their quality‐of‐life needs using an interactive computer program. The intervener then provided education and support tailored to participants' needs. Primary outcome variables included 1) disease‐specific quality of life, including sexual, urinary, and bowel outcomes and cancer worry; 2) depression; 3) dyadic adjustment; and 4) general quality of life. Outcomes data were collected prior to randomization and again at 4 months, 7 months, and 12 months posttreatment.Patients in the intervention arm experienced long‐term improvements in quality‐of‐life outcomes related to sexual functioning and cancer worry compared with patients who received standard care. Baseline depression moderated the impact of the intervention on several other quality‐of‐life outcomes.The findings of the current study indicated that a computer‐assisted, nurse‐driven intervention was capable of providing durable improvements in the quality of life of men who underwent treatment for clinically localized prostate carcinoma. Cancer 2005. © 2005 American Cancer Society.

Published
2005
Full Text
View/download PDF

8. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.

Author

Johns SA, Stutz PV, Talib TL, Cohee AA, Beck-Coon KA, Brown LF, Wilhelm LR, Monahan PO, LaPradd ML, Champion VL, Miller KD, and Giesler RB

Subjects
Adult, Aged, Anxiety drug therapy, Anxiety epidemiology, Anxiety pathology, Breast pathology, Breast Neoplasms drug therapy, Breast Neoplasms epidemiology, Breast Neoplasms pathology, Depression drug therapy, Depression epidemiology, Depression pathology, Female, Humans, Involuntary Commitment, Middle Aged, Neoplasm Recurrence, Local drug therapy, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local prevention & control, Neoplasm Staging, Phobic Disorders drug therapy, Phobic Disorders epidemiology, Phobic Disorders pathology, Quality of Life, Stress Disorders, Post-Traumatic complications, Stress Disorders, Post-Traumatic epidemiology, Stress Disorders, Post-Traumatic pathology, Stress Disorders, Post-Traumatic psychology, Breast Neoplasms psychology, Cancer Survivors, Fear psychology, Neoplasm Recurrence, Local psychology
Abstract

Background: Fear of cancer recurrence (FCR) has a profound negative impact on quality of life (QOL) for many cancer survivors. Breast cancer survivors (BCS) are particularly vulnerable, with up to 70% reporting clinically significant FCR. To the authors' knowledge, evidence-based interventions for managing FCR are limited. Acceptance and commitment therapy (ACT) promotes psychological flexibility in managing life's stressors. The current study examined the feasibility and preliminary efficacy of group-based ACT for FCR in BCS., Methods: Post-treatment BCS (91 patients with stage I-III disease) with clinical FCR randomly were assigned to ACT (6 weekly 2-hour group sessions), survivorship education (SE; 6 weekly 2-hour group sessions), or enhanced usual care (EUC; one 30-minute group coaching session with survivorship readings). FCR severity (primary outcome) and avoidant coping, anxiety, post-traumatic stress, depression, QOL, and other FCR-related variables (secondary outcomes) were assessed at baseline (T1), after the intervention (T2), 1 month after the intervention (T3), and 6 months after the intervention (T4) using intent-to-treat analysis., Results: Satisfactory recruitment (43.8%) and retention (94.5%) rates demonstrated feasibility. Although each arm demonstrated within-group reductions in FCR severity over time, only ACT produced significant reductions at each time point compared with baseline, with between-group differences at T4 substantially favoring ACT over SE (Cohen d for effect sizes, 0.80; P < .001) and EUC (Cohen d, 0.61; P < .01). For 10 of 12 secondary outcomes, only ACT produced significant within-group reductions across all time points. By T4, significant moderate to large between-group comparisons favored ACT over SE and EUC with regard to avoidant coping, anxiety, depression, QOL, and FCR-related psychological distress., Conclusions: Group-based ACT is a feasible and promising treatment for FCR and associated outcomes in BCS that warrants testing in larger, fully powered trials., (© 2019 American Cancer Society.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results